Ravicti Oral Solution 1.1G Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

RAVICTI: Oral solution (1.1g)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

GLYCEROL PHENYLBUTYRATE (gli ser ol fen il bue ti rate) is used to manage the amount of ammonia in the blood of patients with urea cycle disorders. This medicine is not a cure.

In-Depth Information

RAVICTI 1.1g/mL Liquid

NDC: 763250100
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hyperammonemia

Storage Information
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
RAVICTI 1.1g/mL Liquid

Reported Side Effects for RAVICTI 1.1g/mL Liquid

Upset Stomach Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
>7.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
>7.0%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
>7.0%*
Severity: MILD
Onset: DELAYED
High Ammonia Levels Incidence:
>10.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
>10.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
14.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with RAVICTI

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5